miércoles, 7 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 6, 2026

Sezzle and Sea have been highlighted as Zacks Bull and Bear of the Day

View original at finance.yahoo.com
Sezzle and Sea have been highlighted as Zacks Bull and Bear of the Day For Immediate Release Chicago, IL – March 6, 2026 – Zacks Equity Research shares Sezzle SEZL as the Bull of the Day and Sea Ltd…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Sezzle is a Zack Rank #1 (Strong Buy)

    80% confidence

  • Garena is guiding to double digit bookings growth in 2026

    80% confidence

  • Projecting revenue growth of 25 to 30% year over year for FY26

    80% confidence

  • Management emphasized a focus on higher lifetime value subscribers and proprietary shopping features, positioning the company to sustain earnings quality into 2026

    80% confidence

  • Guiding to roughly 25% GMV growth at Shopee for 2026

    80% confidence

  • Adjusted EBITDA at least flat year over year for 2026

    80% confidence

  • Sea Ltd. is a Zacks Rank #5 (Strong Sell)

    80% confidence

  • Guiding to $170 million in adjusted net income, up 31% year over year on a per share basis for FY26

    80% confidence

  • The Zacks Consensus Estimate for American Express' 2026 earnings is pegged at $17.50 per share, implying a 13.8% jump from the year-ago period

    80% confidence

  • Guiding to $4.70 in EPS versus $4.33 expected for FY26

    80% confidence

  • B. Riley Securities reiterated their 'Buy' rating on Sezzle

    80% confidence

Data points we hold from this source

Visa Inc. · payments volume yoy growth8 percent

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
Sezzle and Sea have been highlighted as Zacks Bull and Bear of the Day — Source | Via News | es.VIA.NEWS